Ventyx Biosciences IncNASDAQ:VTYX
- LAST PRICE4.4400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.4100/ 2
- Ask / Lots4.8000/ 10
- Open / Previous Close0.0000 / 4.4400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VTYX |
|---|---|---|
| 09:32 ET | 9415 | 4.62 |
| 09:34 ET | 1074 | 4.47 |
| 09:36 ET | 100 | 4.46 |
| 09:38 ET | 423 | 4.49 |
| 09:41 ET | 1350 | 4.55 |
| 09:43 ET | 500 | 4.5318 |
| 09:45 ET | 100 | 4.54 |
| 09:48 ET | 560 | 4.55 |
| 09:50 ET | 300 | 4.59 |
| 09:52 ET | 1258 | 4.555 |
| 09:54 ET | 700 | 4.55 |
| 09:56 ET | 200 | 4.55 |
| 09:57 ET | 300 | 4.54 |
| 10:01 ET | 1075 | 4.545 |
| 10:08 ET | 1300 | 4.54 |
| 10:15 ET | 159 | 4.555 |
| 10:17 ET | 100 | 4.57 |
| 10:24 ET | 500 | 4.5666 |
| 10:32 ET | 485 | 4.555 |
| 10:33 ET | 100 | 4.58 |
| 10:35 ET | 468 | 4.585 |
| 10:37 ET | 400 | 4.585 |
| 10:39 ET | 400 | 4.59 |
| 10:42 ET | 100 | 4.58 |
| 10:44 ET | 400 | 4.55 |
| 10:46 ET | 104 | 4.56 |
| 10:51 ET | 6010 | 4.55 |
| 10:55 ET | 136 | 4.5516 |
| 10:57 ET | 1889 | 4.56 |
| 11:00 ET | 239 | 4.56 |
| 11:04 ET | 275 | 4.56 |
| 11:06 ET | 200 | 4.56 |
| 11:08 ET | 950 | 4.57 |
| 11:11 ET | 700 | 4.565 |
| 11:13 ET | 200 | 4.565 |
| 11:22 ET | 1710 | 4.55 |
| 11:24 ET | 250 | 4.56 |
| 11:26 ET | 1698 | 4.5527 |
| 11:27 ET | 800 | 4.54 |
| 11:31 ET | 1345 | 4.5415 |
| 11:38 ET | 100 | 4.555 |
| 11:40 ET | 400 | 4.555 |
| 11:44 ET | 650 | 4.55 |
| 11:45 ET | 430 | 4.55 |
| 11:47 ET | 300 | 4.55 |
| 11:49 ET | 200 | 4.545 |
| 11:51 ET | 420 | 4.54 |
| 11:56 ET | 100 | 4.53 |
| 11:58 ET | 100 | 4.53 |
| 12:00 ET | 100 | 4.53 |
| 12:03 ET | 975 | 4.53 |
| 12:05 ET | 2251 | 4.535 |
| 12:07 ET | 511 | 4.53 |
| 12:09 ET | 200 | 4.535 |
| 12:12 ET | 100 | 4.52 |
| 12:16 ET | 610 | 4.53 |
| 12:18 ET | 400 | 4.53 |
| 12:21 ET | 100 | 4.52 |
| 12:25 ET | 162 | 4.515 |
| 12:30 ET | 200 | 4.51 |
| 12:34 ET | 1101 | 4.54 |
| 12:38 ET | 103 | 4.535 |
| 12:39 ET | 7500 | 4.5302 |
| 12:41 ET | 319 | 4.5499 |
| 12:43 ET | 1053 | 4.5484 |
| 12:45 ET | 1100 | 4.53 |
| 12:48 ET | 1635 | 4.53 |
| 12:50 ET | 1065 | 4.51 |
| 12:52 ET | 482 | 4.48 |
| 12:54 ET | 963 | 4.4616 |
| 12:56 ET | 500 | 4.43 |
| 12:57 ET | 4040 | 4.44 |
| 12:59 ET | 1067 | 4.425 |
| 01:01 ET | 1190 | 4.44 |
| 01:03 ET | 1000 | 4.44 |
| 01:06 ET | 1300 | 4.445 |
| 01:08 ET | 530 | 4.43 |
| 01:10 ET | 1743 | 4.43 |
| 01:12 ET | 965 | 4.4218 |
| 01:14 ET | 800 | 4.42 |
| 01:15 ET | 4246 | 4.48 |
| 01:17 ET | 1459 | 4.475 |
| 01:19 ET | 100 | 4.47 |
| 01:21 ET | 200 | 4.485 |
| 01:24 ET | 1000 | 4.48 |
| 01:28 ET | 100 | 4.47 |
| 01:30 ET | 719 | 4.47 |
| 01:32 ET | 200 | 4.47 |
| 01:35 ET | 200 | 4.463 |
| 01:37 ET | 100 | 4.48 |
| 01:39 ET | 130 | 4.4616 |
| 01:44 ET | 200 | 4.465 |
| 01:46 ET | 100 | 4.465 |
| 01:50 ET | 400 | 4.46 |
| 01:57 ET | 958 | 4.46 |
| 02:00 ET | 1112 | 4.47 |
| 02:02 ET | 100 | 4.46 |
| 02:04 ET | 600 | 4.4588 |
| 02:06 ET | 274 | 4.45 |
| 02:08 ET | 100 | 4.455 |
| 02:11 ET | 3567 | 4.5 |
| 02:20 ET | 100 | 4.505 |
| 02:22 ET | 1240 | 4.505 |
| 02:24 ET | 1002 | 4.5 |
| 02:26 ET | 811 | 4.5097 |
| 02:27 ET | 4092 | 4.54 |
| 02:29 ET | 1100 | 4.54 |
| 02:31 ET | 1210 | 4.54 |
| 02:33 ET | 200 | 4.54 |
| 02:36 ET | 776 | 4.535 |
| 02:40 ET | 500 | 4.525 |
| 02:42 ET | 206 | 4.53 |
| 02:44 ET | 1371 | 4.53 |
| 02:45 ET | 222 | 4.54 |
| 02:47 ET | 1500 | 4.555 |
| 02:49 ET | 1000 | 4.555 |
| 02:51 ET | 2026 | 4.55 |
| 02:54 ET | 3142 | 4.56 |
| 02:56 ET | 232 | 4.56 |
| 03:00 ET | 1741 | 4.555 |
| 03:03 ET | 2595 | 4.565 |
| 03:05 ET | 229 | 4.565 |
| 03:07 ET | 100 | 4.57 |
| 03:09 ET | 2851 | 4.57 |
| 03:14 ET | 800 | 4.57 |
| 03:16 ET | 3578 | 4.59 |
| 03:18 ET | 200 | 4.595 |
| 03:21 ET | 994 | 4.58 |
| 03:23 ET | 689 | 4.57 |
| 03:25 ET | 1751 | 4.58 |
| 03:27 ET | 100 | 4.58 |
| 03:32 ET | 1400 | 4.5701 |
| 03:34 ET | 1400 | 4.5708 |
| 03:36 ET | 1600 | 4.575 |
| 03:38 ET | 4412 | 4.5701 |
| 03:39 ET | 562 | 4.57 |
| 03:43 ET | 1118 | 4.575 |
| 03:45 ET | 800 | 4.5785 |
| 03:48 ET | 600 | 4.57 |
| 03:50 ET | 700 | 4.57 |
| 03:52 ET | 21016 | 4.53 |
| 03:54 ET | 4038 | 4.515 |
| 03:56 ET | 11756 | 4.49 |
| 03:57 ET | 18486 | 4.475 |
| 03:59 ET | 28098 | 4.44 |
May 2, 2024
Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024, from 4:05PM ET on Thursday May 02, 2024 by Dow Jones
4:05PM ET on Thursday May 02, 2024 by Dow Jones
May 1, 2024
Lifshitz Law PLLC Announces Investigations of Snowflake Inc. (NYSE:SNOW), The Children's Place, Inc. (NASDAQ:PLCE), Nextdoor Holdings, Inc. (NYSE:KIND), and Ventyx Biosciences, Inc. (NASDAQ:VTYX), from 11:26PM ET on Wednesday May 01, 2024 by Dow Jones
11:26PM ET on Wednesday May 01, 2024 by Dow Jones
Apr 30, 2024
April 30, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VTYX, from 2:16PM ET on Tuesday Apr 30, 2024 by Dow Jones
2:16PM ET on Tuesday Apr 30, 2024 by Dow JonesVTYX DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX, from 1:31PM ET on Tuesday Apr 30, 2024 by Dow Jones
1:31PM ET on Tuesday Apr 30, 2024 by Dow JonesVTYX DEADLINE TODAY: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX, from 1:04PM ET on Tuesday Apr 30, 2024 by Dow Jones
1:04PM ET on Tuesday Apr 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ventyx Biosciences Inc | 313.0M | -1.3x | --- |
Fibrobiologics Inc | 312.8M | -10.4x | --- |
Anavex Life Sciences Corp | 314.0M | -6.9x | --- |
Candel Therapeutics Inc | 317.8M | -8.3x | --- |
Q32 Bio Inc | 313.5M | -0.7x | --- |
Invivyd Inc | 301.6M | -1.4x | --- |
Company Information
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Contact Information
- Headquarters
- 12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
- Phone
- 858-945-2393
- Fax
- 302-655-5049
Executives
- Executive Chairperson of the Board
- Sheila Gujrathi
- President, Chief Executive Officer, Founder, Director
- Raju Mohan
- Chief Financial Officer
- Martin Auster
- Chief Scientific Officer
- John Nuss
- Independent Director
- Onaiza Cadoret-manier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $313.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.29 |
Book Value | $4.12 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
